CRISPR/Cas9 technology was used to flank exon 2 with loxP sites. Exon 2 was deleted via cre-mediated recombination. (J:314187)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count